Clinical Trials Browser

Unknown × INDUSTRY × Vorinostat × Clear all

NCT03561259 2023-02-16

OPTIMUM

Phase 2 Unknown

Neoplasms, Neuroblastoma, Neuroectodermal Tumors

NCT02943642 2016-10-25

Resimmune®

Phase 2 Unknown

DermatologicLymphoid

Mycosis Fungoides, Lymphoma, T-Cell, Cutaneous